# What Is Semaglutide? The GLP-1 Peptide Explained > What is semaglutide? A GLP-1 receptor agonist peptide engineered for once-weekly dosing. The chemistry, the approved uses, and what it does — explained plainly and cited. A redesigned gut-hormone peptide, built to last a week — the chemistry and the uses, in plain language. ## Start here What is semaglutide? In one sentence: it is a lab-built, long-lasting copy of a natural gut hormone that tells your body you have eaten. The hormone is GLP-1 (glucagon-like peptide-1), released after meals; it prompts insulin, slows the stomach, and signals fullness to the brain. The natural version disappears in about two minutes. Chemists rebuilt it so it survives roughly a week, which is why one weekly dose — or a daily pill — works [20]. It is an approved prescription medicine, used for type 2 diabetes, long-term weight management, and protecting the heart and kidneys in certain patients [20]. It is not an experimental research chemical; it is a peptide drug with one of the largest trial records in metabolic medicine. The rest of this page explains the peptide itself. ## Semaglutide peptide: the chemistry, in plain words The semaglutide peptide is a 31-amino-acid chain — a small protein — that shares about 94% of its sequence with human GLP-1 [20]. Three engineering changes turn a two-minute hormone into a once-weekly drug. First, the building block at position 8 is swapped for a non-natural amino acid (Aib, alpha-aminoisobutyric acid) that blocks the enzyme DPP-4 from cutting the chain. Second, a different swap at position 34 removes a second weak point. Third — the clever part — a C18 fatty-acid tail is attached, and that tail clips reversibly onto albumin, the most abundant carrier protein in the blood. Riding on albumin is the whole trick. It keeps the peptide from being filtered out by the kidneys, so instead of vanishing in minutes it circulates for about a week [20]. The molecular formula is `C187H291N45O59` and it weighs roughly 4,114 daltons — large for a drug, small for a protein. ## What it does in the body Once active, semaglutide switches on the GLP-1 receptor and pulls three levers. It tells the pancreas to release insulin, but only when blood sugar is high — a glucose-dependent action, which is why it rarely causes low blood sugar by itself. It quiets glucagon, the hormone that pushes blood sugar up. And it slows how fast the stomach empties, so you feel full longer [5]. The effect people notice most is appetite. Rodent studies traced semaglutide into the brain's appetite hub — the hypothalamic arcuate nucleus and the brainstem — where it activates the neurons that say "full" and silences the ones that say "hungry," cutting food intake without lowering how many calories the body burns [4]. ## What it is approved to do Semaglutide is FDA-approved across several uses and two formulations — a once-weekly injection and a once-daily tablet. The approved indications cover type 2 diabetes, chronic weight management, reduction of major cardiovascular events in adults with established cardiovascular disease, and, since 2025, a form of inflamed fatty-liver disease called MASH [20]. Each of those rests on a major trial: STEP 1 for weight [1], SUSTAIN-6 and SELECT for the heart [2][3], and FLOW for the kidneys [6]. What semaglutide is not: it is not a stimulant, not a "fat burner," and not a substitute for the manufactured product when bought as a compounded or non-pharmaceutical preparation — those fall outside the approved-product evidence base every trial here studied. For the deeper mechanism, see the [Semaglutide research](/research) page; for the honest list of effects and cautions, see [Semaglutide effects](/effects). --- A deep-space reading room for the semaglutide literature — the GLP-1 chemistry charted first and the STEP, SUSTAIN, SELECT and FLOW figures plotted to the studies that measured them, the boxed thyroid warning and the still-unconfirmed signals kept in plain view, and the community reports pinned to one side as anecdote; an observatory for an approved medicine, not a clinic, a prescriber, or a vendor.